Infosys Ltd

Q3 FY25 Earnings Call Analysis

IT - Software

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 4margin: Category 3orderbook: Yes
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- Large deal Total Contract Value (TCV) for Q2 stood at $3.1 billion, with 67% being net new. - For the first half (H1), deal wins amounted to $6.9 billion, with net new deals constituting over 60%. - A significant mega deal with the NHS was announced after the quarter, further strengthening the order pipeline. - The order book visibility is supported by strong large deal wins and a robust pipeline. - No specific figures on total order backlog or pending orders were disclosed beyond the above deal signings. - The deal activity in smaller deals remains steady, similar to previous quarters, with no major uptick noted. - Accounting for these deal wins, the company raised full-year revenue growth guidance to 2%-3%.
💰

fundraise

Any current/future new fundraising through debt or equity?

- There is no mention of any current or future new fundraising through debt or equity in the provided transcript pages. - The company has announced an Rs. 18,000 crores buyback through the tender route at Rs. 1,800 per share, expected to be completed in Q3, subject to shareholder approval. - The Board approved a Rs. 23 interim dividend, which is 9.5% higher than the FY '25 interim dividend. - Cash and investments stood strong at $6.2 billion at the end of the quarter, with no indication of plans for raising additional capital via debt or equity. - Focus appears to be on managing cash flow and returning value to shareholders rather than raising new funds.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Infosys has announced an Rs. 18,000 crore buyback through tender route at Rs. 1,800 per share, expected to be completed in Q3, subject to shareholder approval. - The Board approved a Rs. 23 interim dividend, which is 9.5% higher than the FY '25 interim dividend. - Infosys continues to invest in talent, with over 12,000 freshers hired in the last 6 months, increasing total headcount to 332,000. - The company is investing in sales and marketing, reflected in a 12.8% growth in S&M costs H1 over H1. - Infosys is building local delivery centers and hubs focused on emerging technologies, especially in the U.S., to reduce dependence on work visas. - No specific mentions of large-scale capex/capital investments such as data centers by Infosys itself, but they are partnering with ecosystem partners who are expanding AI data center capacity for future implementation and inference work.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Infosys has increased its revenue growth guidance to 2% to 3% for the full financial year, reflecting confidence in future growth. - Large deal wins remain strong, including a $1.6 billion mega deal expected to start ramping up within the fiscal year. - Despite seasonal softness and lower working days in H2 affecting growth, the company sees strong deal pipelines and client demand, especially in AI, cloud modernization, and automation. - Volumes are expected to remain soft with growth primarily driven by realization (pricing) increases. - AI adoption is creating new growth opportunities, with Infosys delivering over 2,500 Generative AI projects, leveraging AI to enhance productivity and sales. - Expansion in verticals like Financial Services and Manufacturing is robust, with above 5% year-on-year growth ongoing. - The company continues to invest in talent, having onboarded 12,000 freshers recently to support future demand.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Infosys has increased revenue growth guidance for the full fiscal year to 2% to 3%. - Operating margin is expected to remain stable between 20% and 22%. - Q2 operating margin expanded by 20 basis points sequentially to 21%, with continued investments in sales and marketing. - EPS in Q2 grew 13% year-on-year, reaching Rs. 17.6. - Large deal TCV is strong, with a $1.6 billion mega deal adding net new revenue and expected to ramp up this year. - Utilization remains high at 85%, supporting revenue growth. - Free cash flow remains robust at 131% of net profit for the quarter and 120% for H1. - Margin impact from acquisition margins (e.g., Versent) not disclosed, but disciplined approach to maintaining margin profiles in large deals noted. - Overall, the company expects steady earnings and margin growth supported by AI-driven solutions, strong deal wins, and operational efficiencies.